Small Cell Lung Carcinoma
Showing 1 - 25 of >10,000
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Not yet recruiting
- Lung Cancer, Non-small Cell
- Small Cell Lung Cancer
- (no location specified)
Nov 16, 2022
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
NSCLC Trial in Xinxiang (CCCR-NK92 cells)
Enrolling by invitation
- Non-small Cell Lung Cancer
- CCCR-NK92 cells
-
Xinxiang, Henan, ChinaThe first Affiliated Hospital of Xinxiang Medical University
Feb 10, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)
Recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 29, 2022
Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- ADI-PEG 20
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 14, 2022
Proteomics in Small Cell Lung Cancer
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Nov 14, 2022
EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)
Recruiting
- EGFR-Mutated Non-Small-Cell Lung Carcinoma
- Small Cell/Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Stage I Lung Cancer, Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Trial in Atlanta (drug, procedure,
Active, not recruiting
- Stage I Lung Cancer
- +7 more
- Fludeoxyglucose F-18
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 2, 2022
NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- AZD6244
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))
Completed
- Non-small Cell Lung Cancer
- Pembrolizumab
- Radiotherapy (SABR)
-
Melbourne, Victoria, Australia
- +1 more
May 23, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)
Not yet recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Mycophenolate Mofetil
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
May 17, 2022
Small Cell Lung Cancer Trial in Lexington (Rucaparib and Nivolumab)
Recruiting
- Small Cell Lung Cancer
- Rucaparib and Nivolumab
-
Lexington, KentuckyMarkey Cancer Center, University of Kentucky
Aug 9, 2021
Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- Large Cell Neuroendocrine Carcinoma of the Lung
- LB2102
- (no location specified)
Jan 10, 2023
NSCLC, EGF-R Positive NSCLC Trial in Shanghai (Furmonertinib)
Recruiting
- NSCLC
- EGF-R Positive Non-Small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Jan 12, 2022
Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)
Active, not recruiting
- Small Cell Lung Carcinoma
- IP chemotherapy
- IP chemotherapy plus simvastatin
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center , Korea
Apr 4, 2022
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial (RO7616789, Tocilizumab)
Not yet recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
- (no location specified)
Nov 9, 2022
Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- Association of lurbinectedin and durvalumab
- Association of carboplatin and etoposide
-
Bordeaux, FranceInstitut BergoniƩ
Oct 5, 2022
Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)
Enrolling by invitation
- Small Cell Carcinoma, Hypercalcaemic Type
- Ovarian Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 9, 2022
Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- (no location specified)
Oct 24, 2022
Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)
Not yet recruiting
- Lung Cancer
- +2 more
- iC9.GD2.CAR.IL-15 T Infusion
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Nov 16, 2022
Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)
Not yet recruiting
- Small-cell Lung Cancer
- +2 more
- Ablative Radiation
- +3 more
- (no location specified)
Mar 11, 2022
Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Boston, Newton (Contralateral Esophageal Sparing Technique
Completed
- Non-small Cell Lung Carcinoma
- Small Cell Lung Carcinoma
- Contralateral Esophageal Sparing Technique (CEST)
-
Boston, Massachusetts
- +1 more
Dec 8, 2021
Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)
Not yet recruiting
- Lung Cancer
- Small-cell Lung Cancer
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Oct 12, 2022
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Not yet recruiting
- Non Small Cell Lung Cancer
- Small Cell Lung Carcinoma
- Data and Specimen Collection
-
Boston, Massachusetts
- +3 more
Feb 22, 2022